Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells

Akinobu Maeda1, Koh-ichi Nakashiro, Shingo Hara

  • 1Department of Urology, Organ Function Integrative Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.

Insights

Androgen receptor (AR) and c-Met signaling interact in prostate cancer. Inhibiting both AR and c-Met slows cancer growth and may prevent genomic instability in androgen-independent states.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer progression to an androgen-independent state is linked to androgen receptor (AR) alterations and c-Met overexpression.
  • Understanding the interplay between AR and c-Met signaling is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the interaction between androgen receptor (AR) and c-Met signaling pathways in human prostate cancer cells.
  • To determine the role of c-Met signaling in the progression of androgen-independent prostate cancer.

Main Methods:

  • Utilized androgen withdrawal and AR-specific small interfering RNA (siRNA) to modulate AR signaling.
  • Employed siRNA to knockdown both AR and c-Met expression.
  • Conducted microarray analysis to assess gene expression changes.
  • Measured intracellular reactive oxygen species (ROS) and DNA damage accumulation.

Main Results:

  • Androgen withdrawal or AR knockdown reduced cell growth and induced c-Met expression.
  • Simultaneous knockdown of AR and c-Met significantly inhibited prostate cancer cell growth.
  • c-Met activation led to downregulation of DNA repair genes, including 8-oxoguanine DNA glycosylase.
  • Hepatocyte growth factor (HGF) induced ROS production and DNA damage.

Conclusions:

  • c-Met signaling activation contributes to genomic instability and spontaneous mutations in prostate cancer.
  • c-Met signaling promotes survival and growth in androgen-depleted conditions, driving progression to an androgen-independent state.
  • Targeting the c-Met pathway may offer a therapeutic approach for advanced prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...